C Rivas

671 total citations
10 papers, 429 citations indexed

About

C Rivas is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, C Rivas has authored 10 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in C Rivas's work include Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). C Rivas is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). C Rivas collaborates with scholars based in Spain and Chile. C Rivas's co-authors include Josep‐María Ribera, Mar Tormo, Albert Oriol, Eloy del Potro, Teresa Bernal, Pilar Bastida, Carlota Calvo, Evarist Feliú, Jesús María Hernández‐Rivas and Salut Brunet and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and European Journal of Cancer.

In The Last Decade

C Rivas

10 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Rivas Spain 5 313 311 122 85 74 10 429
JM Boiron France 10 253 0.8× 383 1.2× 183 1.5× 60 0.7× 70 0.9× 15 486
Cristina N. Alonso Argentina 11 194 0.6× 165 0.5× 74 0.6× 91 1.1× 71 1.0× 30 384
Lucie Šrámková Czechia 11 347 1.1× 308 1.0× 137 1.1× 66 0.8× 114 1.5× 34 481
Zvenyslava Husak Austria 7 304 1.0× 245 0.8× 108 0.9× 83 1.0× 79 1.1× 8 445
Mircéa Adam France 8 180 0.6× 255 0.8× 56 0.5× 134 1.6× 32 0.4× 13 378
AC Homans United States 7 140 0.4× 142 0.5× 74 0.6× 122 1.4× 41 0.6× 12 324
Alan W. Lankester United Kingdom 7 255 0.8× 332 1.1× 70 0.6× 35 0.4× 79 1.1× 7 394
Georg Borgström Finland 15 330 1.1× 398 1.3× 42 0.3× 95 1.1× 112 1.5× 20 517
Shotaro Iwamoto Japan 6 175 0.6× 153 0.5× 81 0.7× 130 1.5× 83 1.1× 8 364
Kerry E. Barber United Kingdom 10 344 1.1× 285 0.9× 44 0.4× 126 1.5× 129 1.7× 12 478

Countries citing papers authored by C Rivas

Since Specialization
Citations

This map shows the geographic impact of C Rivas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Rivas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Rivas more than expected).

Fields of papers citing papers by C Rivas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Rivas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Rivas. The network helps show where C Rivas may publish in the future.

Co-authorship network of co-authors of C Rivas

This figure shows the co-authorship network connecting the top 25 collaborators of C Rivas. A scholar is included among the top collaborators of C Rivas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Rivas. C Rivas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Huang, Ya-Lin, C Rivas, Valeska Simon, et al.. (2024). The Immunoregulatory and Regenerative Potential of Activated Human Stem Cell Secretome Mitigates Acute-on-Chronic Liver Failure in a Rat Model. International Journal of Molecular Sciences. 25(4). 2073–2073. 3 indexed citations
2.
Barco, E. del, Ricard Mesı́a, Joaquina Martínez-Galán, et al.. (2015). 2802 Phase II study of first-line paclitaxel (PTX) with panitumumab (P) in patients with metastatic or recurrent head and neck cancer: TTCC-2009-03 study. European Journal of Cancer. 51. S558–S558. 1 indexed citations
3.
Oriol, Albert, Susana Vives, Jesús María Hernández‐Rivas, et al.. (2010). Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica. 95(4). 589–596. 202 indexed citations
4.
5.
Sanz, Miguel Á., Guillermo Martı́n, Edo Vellenga, et al.. (2005). Risk-adapted treatment of acute promyelocytic leukemia: Updated results of the Spanish PETHEMA LPA99 Trial using ATRA and anthracycline monochemotherapy. Journal of Clinical Oncology. 23(16_suppl). 6515–6515. 1 indexed citations
6.
Barragán, Eva, Pascual Bolufer, I. Moreno, et al.. (2001). Quantitative Detection of AML1-ETO Rearrangement by Real-Time RT-PCR Using Fluorescently Labeled Probes. Leukemia & lymphoma. 42(4). 747–756. 15 indexed citations
7.
Cervera, José, Marı́a José Calasanz, José A. Martínez-Climent, et al.. (2001). Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.. PubMed. 86(8). 807–13. 49 indexed citations
8.
Ortega, Juan-José, Josep‐María Ribera, Albert Oriol, et al.. (2001). Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.. PubMed. 86(6). 586–95. 25 indexed citations
9.
Rivas, C, et al.. (1992). [Castleman's disease. A multifactorial study].. PubMed. 191(7). 364–8. 1 indexed citations
10.
Rivas, C & H Oliva. (1974). Nuclear bodies in Hodgkin's disease.. PubMed. 9(4). 297–301. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JM Boiron Breakdown of academic impact, for papers by Cristina N. Alonso Breakdown of academic impact, for papers by Lucie Šrámková Breakdown of academic impact, for papers by Zvenyslava Husak Breakdown of academic impact, for papers by Mircéa Adam Breakdown of academic impact, for papers by AC Homans Breakdown of academic impact, for papers by Alan W. Lankester Breakdown of academic impact, for papers by Georg Borgström Breakdown of academic impact, for papers by Shotaro Iwamoto Breakdown of academic impact, for papers by Kerry E. Barber
Rankless by CCL
2026